LAURA VILLAFANE: Open Payments
NPI 1831615178 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 94 payments from 19 companies in 2025. Trend: 2023 $1,518 · 2024 $2,068 · 2025 $1,527
Food & beverage: $1,527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $310 |
| GENZYME CORPORATION | 9 | $251 |
| LEO Pharma Inc. | 13 | $196 |
| Janssen Biotech, Inc. | 11 | $173 |
| UCB, Inc. | 3 | $79 |
| Arcutis Biotherapeutics, Inc. | 5 | $78 |
| Organon LLC | 11 | $71 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $59 |
| Incyte Corporation | 2 | $57 |
| Amgen Inc. | 2 | $48 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, ADBRY, RINVOQ, Bimzelx, Zoryve, ANZUPGO.
Industry payments across FL — which companies pay providers there.
